


Ask a doctor about a prescription for Tussal Antitussicum
Dextromethorphan hydrobromide
Tussal Antitussicum contains dextromethorphan, an antitussive substance.
Dextromethorphan acts by inhibiting the cough center in the central nervous system.
If after 4 days there is no improvement or the patient feels worse, they should consult their doctor.
Taking this medicine may lead to dependence. Therefore, treatment should be short-term.
Before starting treatment with Tussal Antitussicum, the patient should discuss it with their doctor or pharmacist:
Tussal Antitussicum contains dextromethorphan. Due to the risk of overdose, the patient should check if other medicines taken concurrently do not contain dextromethorphan. Particular caution is recommended when using this product in adolescents and young adults, as well as in patients with a history of drug or psychoactive substance abuse.
During treatment with Tussal Antitussicum, the patient should not drink alcohol.
The patient should inform their doctor or pharmacist about all medicines they are currently taking or have recently taken, as well as any medicines they plan to take, including those available without a prescription.
The patient should not take Tussal Antitussicum while being treated with monoamine oxidase inhibitors (medicines used, among others, in depression) and for 14 days after the end of treatment with such medicines (see section "When not to take Tussal Antitussicum"), as dextromethorphan taken together with monoamine oxidase inhibitors and within 14 days after the end of treatment with such medicines may cause collapse, coma, nausea, high fever, and increased blood pressure.
Before taking Tussal Antitussicum, the patient should consult their doctor or pharmacist if they are taking the following medicines:
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult their doctor or pharmacist before taking this medicine.
Pregnancy
Before taking any medicine, the patient should consult their doctor or pharmacist.
The medicine may be used during pregnancy only if, in the doctor's opinion, the benefit to the mother outweighs the potential risk to the fetus.
Breastfeeding
Before taking any medicine, the patient should consult their doctor or pharmacist.
It is not known whether dextromethorphan passes into breast milk, therefore, the medicine should not be used in breastfeeding women.
Tussal Antitussicum may impair the ability to drive and use machines.
If the patient has previously been diagnosed with intolerance to some sugars, they should consult their doctor before taking the medicine.
This medicine should always be taken exactly as described in the patient information leaflet or as directed by a doctor or pharmacist. In case of doubt, the patient should consult their doctor or pharmacist.
The medicine is taken orally.
Forchildren and adolescents from 6 to 16 years of age, Tussal Antitussicum tablets should only be given on
the advice of a doctor.
Children from 6 to 12 years of age
1 tablet every 6-8 hours. The maximum daily dose is 60 mg of dextromethorphan (4 tablets).
Adults and children over 12 years of age
2 tablets every 6-8 hours. The maximum daily dose is 120 mg of dextromethorphan (8 tablets).
Do not exceed the recommended dose.
Children and adolescents
In case of overdose in children, severe side effects may occur, including neurological disorders. Caregivers should not give a higher dose than recommended.
Dose adjustment is not necessary.
If the patient takes a higher dose of Tussal Antitussicum than recommended, the following symptoms may occur: nausea and vomiting, central nervous system stimulation (excitement, nervousness, anxiety, irritability), dizziness, blurred speech, ataxia, blurred vision, involuntary muscle contractions, confusion, drowsiness, impaired consciousness, involuntary rapid eye movements (nystagmus), cardiac disorders (rapid heartbeat), coordination disorders, psychosis with visual hallucinations, and increased excitability.
Other symptoms of a large overdose may include: coma, severe respiratory disorders, and convulsions.
In case of any of the above symptoms, the patient should immediately consult their doctor or go to the hospital.
In case of overdose, symptomatic and supportive treatment is recommended.
Do not take a double dose to make up for a missed dose.
In case of any further doubts about the use of this medicine, the patient should consult their doctor or pharmacist.
Like all medicines, Tussal Antitussicum can cause side effects, although not everybody gets them.
The following side effects may occur during treatment with the medicine:
Gastrointestinal disorders: nausea, vomiting, stomach pain, constipation.
Nervous system disorders:dizziness, drowsiness.
Immune system disorders:allergic reactions: rash, urticaria, angioedema (a severe allergic reaction that causes swelling of the face, lips, tongue, or throat, which may make breathing difficult), bronchospasm (causing difficulty breathing or wheezing).
If the patient experiences any side effects, including any possible side effects not listed in the leaflet, they should inform their doctor or pharmacist. Side effects can be reported directly to the Department for Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products:
Aleje Jerozolimskie 181C, 02-222 Warsaw
phone: +48 22 49 21 301, fax: +48 22 49 21 309
e-mail: [email protected]
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help to gather more information on the safety of the medicine.
Store in a temperature below 25°C.
Store in the original package.
Keep the medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the blister and carton. The expiry date refers to the last day of the month.
Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines they no longer use. This will help protect the environment.
Tussal Antitussicum tablets are round, coated, biconvex, white, with a smooth surface, and have a notch on one side.
The tablet can be divided into two halves.
Packaging:
A carton box containing 10 tablets in a blister pack.
The batch number and expiry date are stated on the outer packaging and blister pack.
The inscription on the blister pack: the first part (embossed with 6 digits) indicates the batch number, and the second part (6 consecutive digits) indicates the expiry date.
Biofarm Sp. z o.o.
ul. Wałbrzyska 13
60-198 Poznań
To obtain more detailed information, the patient should contact the representative of the marketing authorization holder:
Biofarm Sp. z o.o.
ul. Wałbrzyska 13
60-198 Poznań
Poland
phone: 061 66 51 500
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for Tussal Antitussicum – subject to medical assessment and local rules.